Novartis AG (SWX:NOVN)
98.15
+1.49 (1.54%)
Feb 21, 2025, 5:31 PM CET
Novartis AG Revenue
In the year 2024, Novartis AG had annual revenue of $51.72B USD with 10.85% growth. Novartis AG had revenue of $13.56B in the quarter ending December 31, 2024, with 15.13% growth.
Revenue
$51.72B
Revenue Growth
+10.85%
P/S Ratio
4.23
Revenue / Employee
$681.60K
Employees
75,883
Market Cap
193.86B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.72B | 5.06B | 10.85% |
Dec 31, 2023 | 46.66B | 3.20B | 7.36% |
Dec 31, 2022 | 43.46B | -513.00M | -1.17% |
Dec 31, 2021 | 43.97B | -5.92B | -11.87% |
Dec 31, 2020 | 49.90B | 1.22B | 2.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Lonza Group AG | 6.57B |
Alcon | 8.25B |
Galderma Group AG | 3.88B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.09B |
Sonova Holding AG | 3.71B |
Ypsomed Holding AG | 617.07M |
Novartis AG News
- 2 days ago - Novartis Invests $7.5M to Promote Early Prostate Cancer Testing in Vulnerable Communities - CNBC
- 6 days ago - Novartis: Strong Execution With A P/E Discount - Seeking Alpha
- 6 days ago - Key deals this week: Papa John's, Spirit Airlines, Novartis, Banco Santander and more - Seeking Alpha
- 8 days ago - Novartis: Just What The Doctor Ordered - Seeking Alpha
- 11 days ago - Novartis agrees $3bn deal to buy heart drug biotech from Blackstone - Financial Times
- 11 days ago - Novartis to buy Anthos Therapeutics for up to $3.1B - Seeking Alpha
- 11 days ago - Novartis agrees to acquire Anthos for up to $3.1 bln - Reuters
- 11 days ago - Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion - Business Wire